Skip to main content
Chris Holmes, MD, Hematology, Burlington, VT

ChrisEHolmesMDPhD

Hematology Burlington, VT

Clotting Disorder, Hematologic Oncology, Hemophilia & Bleeding Disorder

Professor, Department of Medicine, University of Vermont College of Medicine

Dr. Holmes is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Holmes' full profile

Already have an account?

  • Office

    111 Colchester Ave
    Second floor ACC
    Burlington, VT 05401
    Phone+1 802-847-8400

Education & Training

  • University of Vermont Medical Center
    University of Vermont Medical CenterFellowship, Hematology and Medical Oncology, 2001 - 2004
  • University of Vermont Medical Center
    University of Vermont Medical CenterResidency, Internal Medicine, 1997 - 2000
  • University of Virginia School of Medicine
    University of Virginia School of MedicineClass of 1997

Certifications & Licensure

  • VT State Medical License
    VT State Medical License 1997 - 2026
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Post Discharge Risk of Venous Thromboembolism in a Primary Care Population
    Chris E. Holmes, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Bleeding Risk in a Cohort of Ambulatory Cancer Patients Receiving Outpatient Prophylactic Anticoagulation for Venous Thrombosis Prevention
    Chris E. Holmes, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

  • UVM Cancer Center Rolls Out Custom-Made Immunotherapy
    UVM Cancer Center Rolls Out Custom-Made ImmunotherapyFebruary 22nd, 2023
  • Holcombe Named Director of UVM Cancer Center and Chief of Hematology/Oncology
    Holcombe Named Director of UVM Cancer Center and Chief of Hematology/OncologyApril 13th, 2021